204 related articles for article (PubMed ID: 33623374)
1. Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients.
Perwitasari DA; Febriana SA; Tristiana RS
Patient Prefer Adherence; 2021; 15():329-335. PubMed ID: 33623374
[TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNAs from PBMCs stimulated with culprit drugs enhanced keratinocyte cell death in Stevens-Johnson syndrome/toxic epidermal necrolysis.
Suthumchai N; Buranapraditkun S; Thantiworasit P; Rerknimitr P; Wongpiyabovorn J; Khanaraksombat S; Reantragoon R; Klaewsongkram J
J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1375-1384. PubMed ID: 36840393
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic factors in severe cutaneous drug reactions.
Yang MS; Kang MG; Jung JW; Song WJ; Kang HR; Cho SH; Min KU
Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
[TBL] [Abstract][Full Text] [Related]
4. The interferon-γ-induced protein 10/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.
Yang CW; Cho YT; Hsieh YC; Hsu SH; Chen KL; Chu CY
Br J Dermatol; 2020 Nov; 183(5):909-919. PubMed ID: 32037509
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
6. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
7. Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review.
Pakkir Maideen NM; Barakat IR; Jumale AH
Curr Drug Saf; 2024; 19(2):218-223. PubMed ID: 37151075
[TBL] [Abstract][Full Text] [Related]
8. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
Wolf R; Matz H; Marcos B; Orion E
Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions.
Suzuki M; Koshikawa S; Watanabe H; Inomata N; Yamaguchi Y; Aihara M; Sueki H
J Dermatol; 2023 Apr; 50(4):536-540. PubMed ID: 36540013
[TBL] [Abstract][Full Text] [Related]
10. [Severe skin reactions due to new medications].
Mockenhaupt M; Paulmann M
Hautarzt; 2018 Apr; 69(4):278-289. PubMed ID: 29568997
[TBL] [Abstract][Full Text] [Related]
11. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
13. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
Darlenski R; Kazandjieva J; Tsankov N
Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
[TBL] [Abstract][Full Text] [Related]
15. HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.
Sukasem C; Jantararoungtong T; Kuntawong P; Puangpetch A; Koomdee N; Satapornpong P; Supapsophon P; Klaewsongkram J; Rerkpattanapipat T
Front Pharmacol; 2016; 7():186. PubMed ID: 27486401
[TBL] [Abstract][Full Text] [Related]
16. Differential cytokine profiles produced by anti-epileptic drug re-exposure of peripheral blood mononuclear cells derived from severe anti-epileptic drug patients and non-allergic controls.
Srinoulprasert Y; Kumkamthornkul P; Tuchinda P; Wongwiangjunt S; Sathornsumetee S; Jongjaroenprasert K; Kulthanan K
Cytokine; 2022 Sep; 157():155951. PubMed ID: 35772364
[TBL] [Abstract][Full Text] [Related]
17. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
Kim HK; Kim DY; Bae EK; Kim DW
J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
Bouvresse S; Valeyrie-Allanore L; Ortonne N; Konstantinou MP; Kardaun SH; Bagot M; Wolkenstein P; Roujeau JC
Orphanet J Rare Dis; 2012 Sep; 7():72. PubMed ID: 23009177
[TBL] [Abstract][Full Text] [Related]
19. Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs.
Lee SY; Nam YH; Koh YI; Kim SH; Kim S; Kang HR; Kim MH; Lee JG; Park JW; Park HK; La HO; Kim MY; Park SJ; Kwon YE; Jung JW; Kim SH; Kim CW; Yang MS; Kang MG; Lee JY; Kim JH; Kim SH; Hur GY; Jee YK; Jin HJ; Park CS; Jeong YY; Ye YM
Allergy Asthma Immunol Res; 2019 Mar; 11(2):212-221. PubMed ID: 30661313
[TBL] [Abstract][Full Text] [Related]
20. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.
Lin YT; Chang YC; Hui RC; Yang CH; Ho HC; Hung SI; Chung WH
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):356-64. PubMed ID: 22211830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
